India Glycols: Material Update in Connection with Ennature Bio Pharma Limited
India Glycols (INDIAGLYCO) filed a disclosure titled "Material Update in Connection with Ennature Bio Pharma Limited". The company is valued at about ₹2,181 crore.
What happened
India Glycols (INDIAGLYCO) filed a disclosure with the exchanges on 2 November 2026 at 11:16 PM titled "Material Update in Connection with Ennature Bio Pharma Limited".
Company snapshot
India Glycols is a small-cap company in the Fast Moving Consumer Goods sector, with a market value of about ₹2,181 crore.
The stock last traded at ₹325.4, against a 52-week range of ₹164.1–₹1,222 (73.4% below the high).
Before this filing the shares had moved +7.9% over the month and +43.1% over three months. Average daily turnover over the last 20 sessions was about ₹85.62 crore.
Promoters held 59.63% at the end of Q1 FY27. Foreign institutions owned 2.24% and domestic institutions 5.22%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 2,503 | 73.3 | 23.66 |
| Q2 FY26 | 2,412 | 65.1 | 10.51 |
| Q3 FY26 | 2,551 | 67.6 | 10.79 |
| Q4 FY26 | 2,360 | 86.9 | 13.64 |
| Q1 FY27 | 2,988 | 96.8 | 14.45 |
What history shows
This is not the company's first m&a disclosure: BCEIE has at least 12 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 6.3% on average the next trading day and was up 0.1% on average after five days (9 filings with price data).
Across 77 similar disclosures by other Fast Moving Consumer Goods companies, shares moved −0.4% on average the next day and +0.8% over five days; 39% of them rose the next day.
Market-wide, 2,273 m&a filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 6 Oct 2026 | M&A | +11.9% | +9.7% |
| 8 Sept 2026 | 'Material Update in Connection with Ennature Bio Pharma Limited'. | +8.2% | −7.2% |
| 8 Sept 2026 | 'Material Update in Connection with IGL Spirits Limited'. | +8.2% | −7.2% |
| 7 Sept 2026 | M&A | +10.2% | +2.5% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.